C07D 215/40
Attached in position 8
Official title: attached in position 8
C07D215/40 (Attached in position 8) appears on 275 US grants and 265 published applications in this corpus.
Search patents in C07D- Granted patents
- 275
- Published applications
- 265
- Assignees
- 204
- Inventors
- 1,031
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 4 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 5 | 0 |
| 1990 | 6 | 0 |
| 1991 | 5 | 0 |
| 1992 | 5 | 0 |
| 1993 | 11 | 0 |
| 1994 | 8 | 0 |
| 1995 | 9 | 0 |
| 1996 | 6 | 0 |
| 1997 | 6 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 8 | 0 |
| 2001 | 4 | 1 |
| 2002 | 6 | 7 |
| 2003 | 4 | 10 |
| 2004 | 8 | 15 |
| 2005 | 3 | 12 |
| 2006 | 9 | 10 |
| 2007 | 8 | 17 |
| 2008 | 9 | 12 |
| 2009 | 8 | 15 |
| 2010 | 4 | 12 |
| 2011 | 4 | 10 |
| 2012 | 11 | 8 |
| 2013 | 4 | 13 |
| 2014 | 11 | 18 |
| 2015 | 10 | 7 |
| 2016 | 8 | 5 |
| 2017 | 1 | 8 |
| 2018 | 7 | 6 |
| 2019 | 5 | 11 |
| 2020 | 6 | 13 |
| 2021 | 5 | 11 |
| 2022 | 8 | 11 |
| 2023 | 10 | 11 |
| 2024 | 11 | 12 |
| 2025 | 3 | 4 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Regimens of tafenoquine for prevention of malaria in malaria-naive subjects5 May 2026US 12,616,689 B260 Degrees Pharmaceuticals LLC
- Methods and materials for inhibiting NF-kB activity21 Apr 2026US 12,606,528 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Disubstituted adamantyl derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition for suppressing cancer growth comprising same as active ingredient27 Jan 2026US 12,534,436 B2Onecuregen Co., Ltd.
- Therapeutic compounds and compositions30 Sep 2025US 12,428,376 B2Agios Pharmaceuticals, Inc.
- Synthesis of mavorixafor and intermediates thereof24 Sep 2026US 2026/0285833 A1X4 Pharmaceuticals, Inc.
- Therapeutic compounds24 Sep 2026US 2026/0285836 A1Rutgers, The State University of New Jersey
- Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects13 Aug 2026US 2026/0232651 A160 Degrees Pharmaceuticals LLC
- Therapeutic compounds and compositions13 Aug 2026US 2026/0234110 A1Agios Pharmaceuticals, Inc.
- Methods and materials for increasing level of phosphorylated ampk protein21 May 2026US 2026/0138955 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
Most cited
By later US patents
- Material for luminescence element and luminescence element using the same890US 6,528,187 B1Fuji Photo Film Co., Ltd. · 2003
- Fluorescent indicator dyes for calcium ions238US 4,603,209 AThe Regents of the University of California · 1986
- Chemical compounds as inhibitors of amyloid beta protein production110US 5,624,937 AEli Lilly and Company · 1997
- Fused heterocyclic compounds87US 7,615,552 B2Synta Pharmaceuticals Corp. · 2009
- Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof75US 6,511,990 B1Sloan-Kettering Institute for Cancer Research · 2003